Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Grifols
Grifols
Activities:
Manufacturing
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Regulatory
Grifols Procleix ArboPlex arbovirus screening assay receives CE mark
The assay can detect four major arboviruses: chikungunya, dengue, West Nile and Zika
Manufacturing
Spanish technology collaboration focuses on manufacturing equipment
Grifols and Mondragon will work on jointly developing medical and pharmaceutical-related automation, robotics and instrumentation
Manufacturing
Grifols to exhibit at CPhI Worldwide 2017
Grifols Partnership is a business to business contract development and manufacturing platform that specialises in small molecules intravenous solutions for the pharmaceutical industry
Design & Build
Grifols opens US$100m worldwide operations facility in Dublin, Ireland
Will contain a warehouse and handle labelling, packaging and final conditioning for plasma, intermediate and finished product
Design & Build
ISD completes cold storage facility for Spanish pharmaceutical firm Grifols
The 12-month project involved the design and construction of two temperature-controlled self-supporting structures
Manufacturing
FOYA projects enhanced with GEA Technology
The company supplies equipment to three winners at the ISPE awards
Manufacturing
Grifols opens US$370m plasma production plant in Clayton, NC in the US
The North Fractionation Facility will produce six million litres of plasma a year by 2015
Subscribe now